Home NDC 73607-001 Artesunate
Product NDC 73607-001
11-digit product format 736070001
Labeler code 73607
Product ID 73607-001_943a3ed2-2321-4d46-ac76-763437e53792
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Artesunate
Dosage form KIT
Labeler Amivas, LLC
Application NDA213036
Marketing category NDA
Marketing start 2020-12-11
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213036-001 ARTESUNATE ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213036-001 12121506 2044-02-16 Drug product 2024-10-23 N213036-001 12390442 2044-02-16 U-4433 2026-03-23
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N213036-001 ODE-290 2027-05-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213036-001 ARTESUNATE 110MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-05-26 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 d8e5a09893c0…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213036-001 12121506 2044-02-16 Drug product 2024-10-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213036-001 12390442 2044-02-16 U-4433 2026-03-23 a50c72e98297…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 72 observed states.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 73607-001-10 73607000110 4 KIT in 1 CARTON (73607-001-10) > 1 KIT in 1 KIT * 1 SOLUTION in 1 VIAL * 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL * 1 SOLUTION in 1 VIAL * 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 4 kit 2020-12-11 0000-00-00 No No Current 73607-001-11 73607000111 2 KIT in 1 CARTON (73607-001-11) > 1 KIT in 1 KIT * 1 SOLUTION in 1 VIAL * 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL * 1 SOLUTION in 1 VIAL * 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 2 kit 2020-12-11 0000-00-00 No No Current